Volver al buscador
CPSCCPSC · Productos de consumo·N.º oficial 21089

Imatinib Mesylate Tablets 100 mg, Imatinib Mesylate Tablets 400 mg, Pregabalin Capsules 50 mg, Pregabalin Capsules 75 mg, Pregabalin Capsules 100 mg, Pregabalin Capsules 150 mg, Sevelamer Carbonate Tablets 800 mg, Tadalafil Tablets 5 mg and Tadalafil Tablets 20 mg

Publicado el 25 de febrero de 2021

Resumen

CPSC registra el retiro 21089, publicado el 25 de febrero de 2021. Empresa responsable: Dr. Reddy's Laboratories, Ltd., of India; Unidades reportadas: About 21,400.

Qué peligro representa

The products are prescription medications that were labeled and distributed by Dr. Reddy's for institutional use only. The prescription medications were distributed by third party wholesalers to retail pharmacies and could have been dispensed to consumers. The packaging of the products is not child resistant and can pose a risk of poisoning if the contents are swallowed by young children.

Qué hacer

Consumers should immediately store the recalled medications in a safe location out of reach of children and contact Dr. Reddy's for a full refund.

Recibe un correo si Dr. Reddy's Laboratories vuelve a tener un retiro

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Marca
Dr. Reddy's Laboratories, Ltd., of India
Fabricante
Dr. Reddy's Laboratories, Ltd., of India
Distribuidor
Beginning in 2018, Dr. Reddy's sold the recalled medications to wholesalers. Ultimately, these medications could have been sold to consumers at retail pharmacies in the United States at prices varying based on quantities prescribed, health insurance terms, and other factors.
País
US

Retiros relacionados

Preguntas sobre este retiro

¿Imatinib Mesylate Tablets 100 mg, Imatinib Mesylate Tablets 400 mg, Pregabalin Capsules 50 mg, Pregabalin Capsules 75 mg, Pregabalin Capsules 100 mg, Pregabalin Capsules 150 mg, Sevelamer Carbonate Tablets 800 mg, Tadalafil Tablets 5 mg and Tadalafil Tablets 20 mg fue retirado del mercado?

Sí. CPSC publicó el retiro 21089 el 25 de febrero de 2021. Peligro reportado: The products are prescription medications that were labeled and distributed by Dr. Reddy's for institutional use only. The prescription medications were distributed by third party wholesalers to retail pharmacies and could have been dispensed to consumers. The packaging of the products is not child resistant and can pose a risk of poisoning if the contents are swallowed by young children.

¿Qué debo hacer si tengo este producto?

Consumers should immediately store the recalled medications in a safe location out of reach of children and contact Dr. Reddy's for a full refund.

¿Cómo sé si mi unidad está incluida en el retiro?

Compara los datos de tu producto con los del aviso. Marca: Dr. Reddy's Laboratories, Ltd., of India.

Ver aviso oficial de CPSC(abre en cpsc.gov)